Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Il Yang synthesizes gastric H+/K+-ATPase inhibitors with improved stability

Aug. 25, 1998

New agents for pancreatitis in early development at Sankyo

Aug. 25, 1998

Thymosin alpha 1 receives patent protection for hepatitis C indication

Aug. 24, 1998

Nabi files PLA, ELA for hepatitis B immune globulin

Aug. 21, 1998

New clinical study evaluating INKP-100 now in progress

Aug. 21, 1998

Selective beta3-adrenergic agents reported in development at Tokyo Tanabe

Aug. 19, 1998

Budesonide is superior to mesalamine in the treatment of Crohn's disease

Aug. 19, 1998

Results support development of beta-L-Fd4C as an expanded-spectrum anti-HBV drug

Aug. 18, 1998

FDA okays use of Engerix-B in patients with chronic HCV infection

Aug. 17, 1998

Results announced from primate studies of Nabi-Civacir

Aug. 17, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...